Introduction
Hepatic artery pseudoaneurysm (HAP), which was first described as an uncommon complication of trauma in 1984 by Sandblom [1] , is a rare and serious cause of up- Four days later, the child had a severe hemorrhage relapse, with approximately hematemesis of 300 ml and melena of 200 ml, and his blood pressure quickly decreased to 90/60 mm Hg. Emergency blood transfusion and intravenous fluid infusion were used to keep him stable. A repeat US examination of the abdomen was performed and revealed a 3.6 ! 2.8 cm anechoic area with clear border in the right hepatic lobe which showed arterial flow by color Doppler flow imaging ( fig. 1 a) . The portal vein diameter was normal. These findings suggested an aneurysm. Selective celiac arteriography confirmed the presence of a pseudoaneurysm of the right hepatic artery ( fig. 1 b) on April 13, 2006, and the next day, with use of coils, transcatheter arterial embolization was performed, with successful occlusion of the pseudoaneurysm ( fig. 1 c) . The patient recovered uneventfully without further bleeding. Nine days later US showed the absence of the anechoic area ( fig. 1 d) . The boy was discharged without any residual symptoms 11 days afterwards. At follow-up 2 years and 6 months later, the patient remained asymptomatic and was leading a normal life.
Discussion
UGI hemorrhage from a HAP is a rare but serious condition. In the majority of cases reported it was described as hemobilia [1, 4] . A pseudoaneurysm is a pulsatile hematoma due to a leakage of blood through a tear or disruption of the arterial wall and blood is contained only by hepatic parenchyma or surrounding hematoma. The HAP can rupture into the biliary system, causing hematobilia with hematemesis and/or melena. The causes of HAP include trauma, liver biopsy, infection or inflammation due to septic emboli or pancreatitis, radiofrequency ablation therapy, laparoscopic cholecystectomy and liver transplantation [2] [3] [4] . We believe the most likely sequence of events in our patient was that the pseudoaneurysm developed after the hepatic injury and then ruptured into the bile ducts, resulting in hemobilia.
Hemorrhage from a HAP is life-threatening, with a mortality rate of 9% in a recent series [5] . The high morbidity and mortality associated with pseudoaneurysms emphasize the importance of early diagnosis and treatment. The diagnosis is frequently delayed because it is unsuspicious presenting as fever, bile leak, hepatic dysfunction, abdominal pain, hematemesis, melena, anemia, hypovolemia or jaundice. The classic Quincke triad (UGI hemorrhage, upper abdominal pain and jaundice) occurred individually in 73, 52 and 30% of cases, with all 3 components occurring in only 22% of patients [6] . In our patient, the single mode of presentation was UGI hemor- rhage with no pain or jaundice. Nevertheless, the history of hepatic trauma and hematemesis with melena were highly suggestive of hemobilia from a HAP. Selective arteriography is the standard and the most sensitive test for diagnosis. One previous report showed that 100% of HAPs were detected by selective arteriography in a series of 10 patients, compared with only 67% detected by CT and 33% detected by Doppler US [7] . A pseudoaneurysm can sometimes be diagnosed with color Doppler US [3] , which is also useful for follow-up assessment of an embolized aneurysm. In our patient, only the second US showed an anechoic area which was suggestive of an aneurysm. It was suspected that the first US was performed when the pseudoaneurysm was just evacuated due to bleeding. By contrast, the second US was obtained when the pseudoaneurysm had refilled after treatment of the patient with blood transfusion and intravenous fluids. Bleeding is often intermittent and it may be necessary to repeat the US. Occasionally a large aneurysm may be diagnosed by CT or magnetic resonance imaging [8] . Although HAP has been incidentally detected by endoscopic retrograde cholangiopancreatography, this procedure is not routinely recommended. Angiography is still the standard diagnostic choice that also provides accurate localization and an arterial road map essential for planning management.
Although HAP can resolve spontaneously through thrombosis [3] , because there is a high risk of rupture, embolization or surgery are advocated as treatment choices when a HAP is detected. Angiographic embolization is an effective method of treatment, with a reported success rate of 80-100% [9, 10] . For high-risk patients, embolization is preferred and is well tolerated by the liver, provided the portal vein is patent [9, 10] . A variety of embolic agents, such as gelatin sponge, polyvinyl alcohol, coils, N-butyl-cyanoacrylate and thrombin, have been employed for embolization [9, 10] . Arterial stents and detachable silicone balloons have also been utilized. The choice of embolic material depends on the site and the size of the vessels to be occluded and on the characteristics of the lesion. In this case, we chose coils and treated the pseudoaneurysm successfully. Surgical intervention may be required when embolization fails, or if it follows orthotopic liver transplantation or an associated pseudocyst [11] . Hepatic lobectomy and debridement accompanied by ligation of the pseudoaneurysm are the two surgical approaches that have been successfully employed [4, 12] .
Conclusion
This report shows that HAP should be considered as a possible cause of UGI hemorrhage following known hepatic injury. A high index of suspicion and repeated Doppler US when necessary with a timely selective arteriography are required for diagnosis. Embolization is an effective therapy, but surgical intervention may be needed if embolization fails.
